LLOYD RONALD K. 4
4 · AZIYO BIOLOGICS, INC. · Filed Oct 13, 2020
Insider Transaction Report
Form 4
LLOYD RONALD K.
DirectorPresident and CEO
Transactions
- Conversion
Series A Convertible Preferred Stock
2020-10-13−111,788→ 0 total→ Class A Common Stock (14,586 underlying) - Conversion
Class A Common Stock
2020-10-13+14,586→ 14,586 total
Footnotes (1)
- [F1]Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering. In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering).